METHOD FOR EXTRACTING HERBS FOR TREATMENT OF PCOD (POLY-CYSTIC OVARIAN DISORDER)

Abstract

ABSTRACT A method (100) for extracting herbs for treatment of PCOD (Poly-cystic ovarian disorder). Further, the method comprising extracting herbal components from Cinnamon, Fenugreek, Liquorice, Shatavari and Shatapushpa, at step 102. Further, isolating specific molecules from the herbal components, at step 104. Further, incorporating specific molecules via in vivo and in vitro methods, at step 106. Further, conducting clinical trials, at step 108. Further, the clinical trials are conducted to to study symptoms, interventions, diagnosis, and etiology of PCOD. <>

Specification

Description:FIELD OF THE DISCLOSURE
[0001] This invention generally relates to a field of treatment for polycystic ovarian disorder (PCOD) and, in particular to a method for extracting herbal components for the treatment of PCOD.
BACKGROUND

[0002] The subject matter discussed in the background section should not be assumed to be prior art merely as a result of its mention in the background section. Similarly, a problem mentioned in the background section or associated with the subject matter of the background section should not be assumed to have been previously recognized in the prior art. The subject matter in the background section merely represents different approaches, which in and of themselves may also correspond to implementations of the claimed technology.
[0003] Poly-cystic ovarian disorder (PCOD) is a prevalent endocrine disorder affecting a significant number of women worldwide, particularly during their reproductive years. It is characterized by hormonal imbalances, irregular menstrual cycles, and the pr , Claims:1. A method (100) for extracting herbs for treatment of PCOD (Poly-cystic ovarian disorder), the method comprising:
extracting herbal components from Cinnamon, Fenugreek, Liquorice, Shatavari and Shatapushpa, at step 102;
isolating specific molecules from the herbal components, at step 104;
incorporating specific molecules via in vivo and in vitro methods, at step 106; and
conducting clinical trials, at step 108.

2. The method (100) as claimed in claim 1, the clinical trials are conducted to study symptoms, interventions, diagnosis, and etiology of PCOD.

Documents